Desirial PLUS: Injectable hyaluronic acid for the improvement of the aesthetic appearance of the vulva-vaginal area.

DESIRIAL Plus is a more elastic gel, designed for atrophic remodeling of the labia majora. A protection of the labia minora can be observed as a consequence of this aesthetic correction.

DESIRIAL is the world's first range of non-animal, biodegradable injectable hydrogels, exclusively developed to preserve women's intimate health. DESIRIAL products are designed and manufactured in France by Vivacy Laboratories, specialists in aesthetic and anti-ageing medicine.

DESIRIAL is available in two gel formulations: DESIRIAL and DESIRIAL PLUS. They have different hyaluronic acid concentrations and viscosity and elasticity properties, so that your doctor can select precisely the most suitable product for your specific needs. 

DESIRIAL® products are based on VIVACY's exclusive and patented IPN-Like technology, with stabilized hyaluronic acid and antioxidant mannitol.

INDICATIONS FOR DESIRIAL Plus INJECTIONS 

• Hypotrophy, atrophy of the labia majora (volume loss) 

• Aesthetic reasons 

RESULTS AFTER A DESIRIAL Plus INJECTION

• Strengthening of the protective function of the labia majora induced by volume increase

• Improvement of the aesthetic appearance of the vulva-vaginal area

VIVACY's IPN-Like technology is a unique and patented technology (since 2007). It has acquired renowned effectiveness and tolerance in aesthetic and anti-ageing medicine with the STYLAGE® range of dermal fillers.

DESIRIAL PLUS is a more elastic gel designed for the remodeling of the labia majora. A protection of the labia minora can be observed as a consequence of this aesthetic correction.

DESIRIAL PLUS can also be used for labia majora atrophy. 

After a certain age, the tissue tends to shrink, especially around the labia majora. This can damage the natural protection of the vulva and lead to localized pain. Hyaluronic acid recreates the volume of the labia majora, thus protecting the vulva.

How can a hyaluronic acid injection help women with vulvovaginal disorders?

The injections release hyaluronic acid directly into the tissues of the vulva-vaginal area to contribute to its effective hydration. This type of injection indirectly provides mechanical pressure on the cells that constitute the vulvovaginal mucosa, thereby increasing their activity.

This leads to the synthesis of elastin and collagen fibres and improves the quality of the vulvovaginal mucosa.

HYALURONIC ACID: MOISTURIZING ACTION 

Hyaluronic acid is a molecule naturally present in the human body, especially in the skin and mucous membranes. It has the particularity of retaining up to 1000 times its weight in water, contributing to the hydration and tone of the concerned tissues.

Hyaluronic acid has a short half-life and is water soluble, so it must be cross-linked to stabilize the product. This process will link the molecules together using the patented IPN-Like Technology and will result in a cohesive gel that will last for several months.

As a result, DESIRIAL® is able to maintain its moisturizing properties for several months.

ANTIOXIDANT MANNITOL: PROTECTIVE ACTION

Mannitol is an antioxidant incorporated in DESIRIAL® products to limit the deterioration of the gel immediately after the injection.

It collects the free radicals generated by the penetration of the needle or cannula during the injection. As a result, mannitol helps to protect the hyaluronic acid molecules during the first hours after the injection.

This technology involves the interpenetration of two single-phase cross-linked hyaluronic acid networks to stabilize the hyaluronic acid for safe and long-lasting therapeutic effects.

VIVACY LABORATORIES ARE SPECIALISED IN THE DESIGN, PRODUCTION AND DISTRIBUTION OF HIGH QUALITY INJECTABLE MEDICAL DEVICES, USED IN THE ANTI-AGEING FIELD, PARTICULARLY IN AESTHETIC MEDICINE. VIVACY HAS DEVELOPED AND PATENTED IPN-LIKE TECHNOLOGY TO STABILIZE HYALURONIC ACID AND INCREASE ITS REMANENCE IN THE TISSUE.